Arthur He HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
74.1%
Neutral
25.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $25 |
89%
upside
| 1 | +0.61% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Buy
Maintained
| $135 |
226%
upside
| 5 | +79% |
0
%
| 16 Dec ‘25 23 days ago |
|
|
|
Buy
Maintained
| $90 |
89%
upside
| 3 | +33% |
0
%
| 10 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $7 |
324%
upside
| 3 | -3.5% |
0
%
| 15 Aug ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $1.24 | – | 3 | +37% |
–
| 5 Aug ‘25 5 months ago |
|
|
|
Buy
Assumed
| $17 |
11%
upside
| 1 | +71% |
0
%
| 30 Jul ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -49% |
0
%
| 29 Jul ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $20 |
277%
upside
| 4 | +9.2% |
0
%
| 17 Jun ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| – | – | 3 | -27% |
0
%
| 20 May ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| – | – | 1 | – |
–
| 31 Mar ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 10 Jan ‘25 1 year ago |
|